Skip to content
Twitter page opens in new windowLinkedin page opens in new windowInstagram page opens in new window
investorenquiries@pharmaust.com+61 8 9202 6814
PharmAust (PAA)
PharmAust (PAA)
  • HOME
  • ABOUT
    • Company Overview
    • PharmAust Management
    • Board
    • Corporate Directory
  • PIPELINE & TRIALS
    • Therapeutic Pipeline
    • MPL Veterinary Trial Details
    • MPL and Veterinary Trials
    • Veterinary Trial Testimonials
    • MPL and Human Trials
    • Publications
    • Pet Cancer Information Service
    • Motor Neuron Disease Trial
  • INVESTOR CENTRE
    • PhamAust AGM 2022
    • News & Announcements
    • Company Research
    • Financial Reports
    • Annual Reports
    • Investor Presentations
    • Corporate Governance
    • Top 20 Shareholders
  • MEDIA
    • Podcast Episode 18: Dr Kim Agnew, PharmAust
    • Fireside Chat with Dr Roger Aston
    • Fireside Chat with Dr Kim
    • PharmAust Webinar
    • Epichem Webinar
    • BB PAA Video – September 2021
    • OHD Benchtop Flow Reactor Launch
    • Dr Richard Mollard – Full Interview Ticker TV – 17th June 2020
    • Interview with TechInvest – May 2020
    • Dr. Richard Mollard – 6IX Interview March 2020
    • PharmAust In the News
    • PharmAust Videos
    • PharmAust New Cancer Treatment
    • PharmAust and Catalent Commence GMP Tablet Manufacture (Audio)
    • PharmAust on Youtube
  • CONTACT
  • HOME
  • ABOUT
    • Company Overview
    • PharmAust Management
    • Board
    • Corporate Directory
  • PIPELINE & TRIALS
    • Therapeutic Pipeline
    • MPL Veterinary Trial Details
    • MPL and Veterinary Trials
    • Veterinary Trial Testimonials
    • MPL and Human Trials
    • Publications
    • Pet Cancer Information Service
    • Motor Neuron Disease Trial
  • INVESTOR CENTRE
    • PhamAust AGM 2022
    • News & Announcements
    • Company Research
    • Financial Reports
    • Annual Reports
    • Investor Presentations
    • Corporate Governance
    • Top 20 Shareholders
  • MEDIA
    • Podcast Episode 18: Dr Kim Agnew, PharmAust
    • Fireside Chat with Dr Roger Aston
    • Fireside Chat with Dr Kim
    • PharmAust Webinar
    • Epichem Webinar
    • BB PAA Video – September 2021
    • OHD Benchtop Flow Reactor Launch
    • Dr Richard Mollard – Full Interview Ticker TV – 17th June 2020
    • Interview with TechInvest – May 2020
    • Dr. Richard Mollard – 6IX Interview March 2020
    • PharmAust In the News
    • PharmAust Videos
    • PharmAust New Cancer Treatment
    • PharmAust and Catalent Commence GMP Tablet Manufacture (Audio)
    • PharmAust on Youtube
  • CONTACT

Author Archives: PharmAust

February 26, Appendix 4D & Half Year Report

Financial Reports 2021, News and Announcements 2021By PharmAustFebruary 26, 2021

210226_Appendix 4D, half yearly report

February 15, Canine Monepantel Phase IIb Lymphoma Trial Update

News and Announcements 2021By PharmAustFebruary 14, 2021

210215_PhaseIIb_update

February 10, LUMC Covid-19 Research Update

News and Announcements 2021By PharmAustFebruary 10, 2021

210210_LUMC_Update

January 31, Top 20 Shareholders

News and Announcements 2021, Top 20 ShareholdersBy PharmAustFebruary 1, 2021

210131_Top20Shareholders

January 27, Appendix 4C and Quarterly Update

News and Announcements 2021By PharmAustJanuary 27, 2021

210127_Appendix 4C and Quarterly Update

January 22, Epichem Awarded $200k e-Waste Grant

News and Announcements 2021By PharmAustJanuary 22, 2021

210122_Epichem Award

January 9, PAA LUMC COVID-19 Research Update

News and Announcements 2021By PharmAustJanuary 8, 2021

210109_PAA_LUMC Update

December 31, Top 20 Shareholders

News & Announcements 2020, Top 20 ShareholdersBy PharmAustJanuary 4, 2021

201231_Top_Holders_Report (91)

December 23, PharmAust Commences MPL Manufacture for Human Clinical Trials

News & Announcements 2020By PharmAustDecember 23, 2020

201223_PAA_Syngene_FightMND_Manufacture

December 22, PharmAust Set to Commence Phase IIb Anticancer Canine Trial

News & Announcements 2020By PharmAustDecember 22, 2020

201222_PhaseIIbcaninetrial

←1
2345678
…910111213…
14151617181920212223242526272829303132333435363738394041424344454647
48→
MENU
  • Home
  • About Us
  • Pipeline & Trials
  • Investor Centre
  • Media
  • Contact Us
SUBSCRIBE TO OUR NEWSLETTER


Facebook
Facebook
fb-share-icon
Twitter
YouTube
TWITTER

PharmAust Follow

PharmAust is a clinical-stage biotech company developing drug discovery IP to treat cancer, viral and neurological diseases. ASX: $PAA FSE: $ECQ

PharmAust
pharmaust PharmAust @pharmaust ·
2h

Pandemic Pet Adoptions Propel Rise of a $500 Billion Global Market
Via ⁦@Bloomberg⁩ https://www.bloomberg.com/news/articles/2023-03-24/pet-industry-outlook-is-strong-despite-rising-costs-of-food-vet-care

Reply on Twitter 1641241590726561792 Retweet on Twitter 1641241590726561792 1 Like on Twitter 1641241590726561792 1 Twitter 1641241590726561792
pharmaust PharmAust @pharmaust ·
4h

MND Trial Completes Enrolment of Cohort 2 and Prepares for Interim Analysis

Reply on Twitter 1641205801892339713 Retweet on Twitter 1641205801892339713 Like on Twitter 1641205801892339713 8 Twitter 1641205801892339713
pharmaust PharmAust @pharmaust ·
29 Mar

Write up on $PAA/@PharmAust in today's @Australian @aus_business

Reply on Twitter 1640893023193284609 Retweet on Twitter 1640893023193284609 2 Like on Twitter 1640893023193284609 14 Twitter 1640893023193284609
Load More
Copyright © 2023 PharmAust. All rights reserved.
nil

Website Design & Digital Marketing Perth by Total Click Solutions

Go to Top